[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

November 2023 | 138 pages | ID: FB279E3929E1EN
IMARC Group

US$ 2,499.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global formulation development outsourcing market size reached US$ 22.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.89% during 2022-2028.

Formulation development refers to the process of determining patentability, lifecycle, and the success of the pharmaceutical product. It also involves pre-formulation, including analytical assay development and characterization, excipient screening to stabilize or enhance the solubility of the product and dosage form development. It is often outsourced due to time pressure and a lack of internal resources. Formulation development outsourcing also offers numerous benefits, such as compressing timelines, accessing expertise, and providing extra insurance against product failure.

Formulation Development Outsourcing Market Trends:
The growing prevalence of chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer’s disease, is catalyzing the demand for the discovery and development of new drugs. This, in turn, represents one of the key factors resulting in the formulation development services being outsourced to contract research organizations (CROs) around the world. Besides this, there is a rise in the need to overcome the risk and save time and money involved in passing the drug through the development pipeline. As a result, leading pharmaceutical and biotechnological companies worldwide are partnering with outsourcing services in the early phases of the drug development process. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. Furthermore, expanding healthcare expenditure by business enterprises and governing agencies of several countries is creating a favorable market outlook. Moreover, the coronavirus disease (COVID-19) outbreak has positively influenced the need for clinical trials to find an effective treatment against the contagious infection. This has resulted in extensive investments in research and development (R&D) to develop therapeutics, which is projected to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global formulation development outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, dosage form, application and end user.

Breakup by Service:

Pre-formulation Services
Discovery and Preclinical Services
Analytical Services
Formulation Optimization
Phase I
Phase II
Phase III
Phase IV

Breakup by Dosage Form:

Injectable
Oral
Topical
Others

Breakup by Application:

Oncology
Genetic Disorders
Neurology
Infectious Diseases
Respiratory
Cardiovascular
Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies
Government and Academic Institutes

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy’s Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global formulation development outsourcing market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global formulation development outsourcing market?
What are the key regional markets?
What is the breakup of the market based on the service?
What is the breakup of the market based on the dosage form?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global formulation development outsourcing market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE

2 SCOPE AND METHODOLOGY

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
  2.3.1 Primary Sources
  2.3.2 Secondary Sources
2.4 Market Estimation
  2.4.1 Bottom-Up Approach
  2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 EXECUTIVE SUMMARY

4 INTRODUCTION

4.1 Overview
4.2 Key Industry Trends

5 GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 MARKET BREAKUP BY SERVICE

6.1 Pre-formulation Services
  6.1.1 Market Trends
  6.1.2 Key Segments
    6.1.2.1 Discovery and Preclinical Services
    6.1.2.2 Analytical Services
  6.1.3 Market Forecast
6.2 Formulation Optimization
  6.2.1 Market Trends
  6.2.2 Key Segments
    6.2.2.1 Phase I
    6.2.2.2 Phase II
    6.2.2.3 Phase III
    6.2.2.4 Phase IV
  6.2.3 Market Forecast

7 MARKET BREAKUP BY DOSAGE FORM

7.1 Injectable
  7.1.1 Market Trends
  7.1.2 Market Forecast
7.2 Oral
  7.2.1 Market Trends
  7.2.2 Market Forecast
7.3 Topical
  7.3.1 Market Trends
  7.3.2 Market Forecast
7.4 Others
  7.4.1 Market Trends
  7.4.2 Market Forecast

8 MARKET BREAKUP BY APPLICATION

8.1 Oncology
  8.1.1 Market Trends
  8.1.2 Market Forecast
8.2 Genetic Disorders
  8.2.1 Market Trends
  8.2.2 Market Forecast
8.3 Neurology
  8.3.1 Market Trends
  8.3.2 Market Forecast
8.4 Infectious Diseases
  8.4.1 Market Trends
  8.4.2 Market Forecast
8.5 Respiratory
  8.5.1 Market Trends
  8.5.2 Market Forecast
8.6 Cardiovascular
  8.6.1 Market Trends
  8.6.2 Market Forecast
8.7 Others
  8.7.1 Market Trends
  8.7.2 Market Forecast

9 MARKET BREAKUP BY END USER

9.1 Pharmaceutical and Biopharmaceutical Companies
  9.1.1 Market Trends
  9.1.2 Market Forecast
9.2 Government and Academic Institutes
  9.2.1 Market Trends
  9.2.2 Market Forecast

10 MARKET BREAKUP BY REGION

10.1 North America
  10.1.1 United States
    10.1.1.1 Market Trends
    10.1.1.2 Market Forecast
  10.1.2 Canada
    10.1.2.1 Market Trends
    10.1.2.2 Market Forecast
10.2 Asia-Pacific
  10.2.1 China
    10.2.1.1 Market Trends
    10.2.1.2 Market Forecast
  10.2.2 Japan
    10.2.2.1 Market Trends
    10.2.2.2 Market Forecast
  10.2.3 India
    10.2.3.1 Market Trends
    10.2.3.2 Market Forecast
  10.2.4 South Korea
    10.2.4.1 Market Trends
    10.2.4.2 Market Forecast
  10.2.5 Australia
    10.2.5.1 Market Trends
    10.2.5.2 Market Forecast
  10.2.6 Indonesia
    10.2.6.1 Market Trends
    10.2.6.2 Market Forecast
  10.2.7 Others
    10.2.7.1 Market Trends
    10.2.7.2 Market Forecast
10.3 Europe
  10.3.1 Germany
    10.3.1.1 Market Trends
    10.3.1.2 Market Forecast
  10.3.2 France
    10.3.2.1 Market Trends
    10.3.2.2 Market Forecast
  10.3.3 United Kingdom
    10.3.3.1 Market Trends
    10.3.3.2 Market Forecast
  10.3.4 Italy
    10.3.4.1 Market Trends
    10.3.4.2 Market Forecast
  10.3.5 Spain
    10.3.5.1 Market Trends
    10.3.5.2 Market Forecast
  10.3.6 Russia
    10.3.6.1 Market Trends
    10.3.6.2 Market Forecast
  10.3.7 Others
    10.3.7.1 Market Trends
    10.3.7.2 Market Forecast
10.4 Latin America
  10.4.1 Brazil
    10.4.1.1 Market Trends
    10.4.1.2 Market Forecast
  10.4.2 Mexico
    10.4.2.1 Market Trends
    10.4.2.2 Market Forecast
  10.4.3 Others
    10.4.3.1 Market Trends
    10.4.3.2 Market Forecast
10.5 Middle East and Africa
  10.5.1 Market Trends
  10.5.2 Market Breakup by Country
  10.5.3 Market Forecast

11 SWOT ANALYSIS

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 VALUE CHAIN ANALYSIS

13 PORTERS FIVE FORCES ANALYSIS

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 PRICE ANALYSIS

15 COMPETITIVE LANDSCAPE

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
  15.3.1 Aizant Drug Research Solutions Private Limited
    15.3.1.1 Company Overview
    15.3.1.2 Product Portfolio
  15.3.2 Catalent Inc.
    15.3.2.1 Company Overview
    15.3.2.2 Product Portfolio
    15.3.2.3 Financials
    15.3.2.4 SWOT Analysis
  15.3.3 Charles River Laboratories
    15.3.3.1 Company Overview
    15.3.3.2 Product Portfolio
    15.3.3.3 Financials
    15.3.3.4 SWOT Analysis
  15.3.4 Dr. Reddy’s Laboratories Ltd.
    15.3.4.1 Company Overview
    15.3.4.2 Product Portfolio
    15.3.4.3 Financials
    15.3.4.4 SWOT Analysis
  15.3.5 Emergent BioSolutions Inc.
    15.3.5.1 Company Overview
    15.3.5.2 Product Portfolio
    15.3.5.3 Financials
    15.3.5.4 SWOT Analysis
  15.3.6 Intertek Group plc
    15.3.6.1 Company Overview
    15.3.6.2 Product Portfolio
    15.3.6.3 Financials
    15.3.6.4 SWOT Analysis
  15.3.7 Irisys LLC (Recro Pharma)
    15.3.7.1 Company Overview
    15.3.7.2 Product Portfolio
  15.3.8 Laboratory Corporation of America Holdings
    15.3.8.1 Company Overview
    15.3.8.2 Product Portfolio
    15.3.8.3 Financials
    15.3.8.4 SWOT Analysis
  15.3.9 Lonza Group AG
    15.3.9.1 Company Overview
    15.3.9.2 Product Portfolio
    15.3.9.3 Financials
    15.3.9.4 SWOT Analysis
  15.3.10 Piramal Pharma Solutions
    15.3.10.1 Company Overview
    15.3.10.2 Product Portfolio
    15.3.10.3 Financials
  15.3.11 Quotient Sciences
    15.3.11.1 Company Overview
    15.3.11.2 Product Portfolio
  15.3.12 Syngene International Limited (Biocon Limited)
    15.3.12.1 Company Overview
    15.3.12.2 Product Portfolio
    15.3.12.3 Financials
  15.3.13 Thermo Fisher Scientific Inc.
    15.3.13.1 Company Overview
    15.3.13.2 Product Portfolio
    15.3.13.3 Financials
    15.3.13.4 SWOT Analysis

LIST OF TABLES

Table 1: Global: Formulation Development Outsourcing Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Formulation Development Outsourcing Market Forecast: Breakup by Service (in Million US$), 2023-2028
Table 3: Global: Formulation Development Outsourcing Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
Table 4: Global: Formulation Development Outsourcing Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Formulation Development Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Formulation Development Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Formulation Development Outsourcing Market: Competitive Structure
Table 8: Global: Formulation Development Outsourcing Market: Key Players

LIST OF FIGURES

Figure 1: Global: Formulation Development Outsourcing Market: Major Drivers and Challenges
Figure 2: Global: Formulation Development Outsourcing Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Formulation Development Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Formulation Development Outsourcing Market: Breakup by Service (in %), 2022
Figure 5: Global: Formulation Development Outsourcing Market: Breakup by Dosage Form (in %), 2022
Figure 6: Global: Formulation Development Outsourcing Market: Breakup by Application (in %), 2022
Figure 7: Global: Formulation Development Outsourcing Market: Breakup by End User (in %), 2022
Figure 8: Global: Formulation Development Outsourcing Market: Breakup by Region (in %), 2022
Figure 9: Global: Formulation Development Outsourcing (Pre-formulation Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Formulation Development Outsourcing (Pre-formulation Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Formulation Development Outsourcing (Formulation Optimization) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Formulation Development Outsourcing (Formulation Optimization) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Formulation Development Outsourcing (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Formulation Development Outsourcing (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Formulation Development Outsourcing (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Formulation Development Outsourcing (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Formulation Development Outsourcing (Topical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Formulation Development Outsourcing (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Formulation Development Outsourcing (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Formulation Development Outsourcing (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Formulation Development Outsourcing (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Formulation Development Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Formulation Development Outsourcing (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Formulation Development Outsourcing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Formulation Development Outsourcing (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Formulation Development Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Formulation Development Outsourcing (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Formulation Development Outsourcing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Formulation Development Outsourcing (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Formulation Development Outsourcing (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Formulation Development Outsourcing (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Formulation Development Outsourcing (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Formulation Development Outsourcing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Formulation Development Outsourcing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: North America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: North America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: United States: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: United States: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Canada: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Canada: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Asia-Pacific: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Asia-Pacific: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: China: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: China: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Japan: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Japan: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: India: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: India: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: South Korea: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: South Korea: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Australia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Australia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Indonesia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Indonesia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Europe: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Europe: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Germany: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Germany: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: France: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: France: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: United Kingdom: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: United Kingdom: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Italy: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Italy: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Spain: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Spain: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Russia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Russia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Latin America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Latin America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Brazil: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Brazil: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Mexico: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Mexico: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Middle East and Africa: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Middle East and Africa: Formulation Development Outsourcing Market: Breakup by Country (in %), 2022
Figure 87: Middle East and Africa: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Global: Formulation Development Outsourcing Industry: SWOT Analysis
Figure 89: Global: Formulation Development Outsourcing Industry: Value Chain Analysis
Figure 90: Global: Formulation Development Outsourcing Industry: Porter's Five Forces Analysis


More Publications